Atyr Pharma Inc (ATYR)

EBITDA Growth

45.28%

Quarterly · Period ending:

ATYR logo

ATYR EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported45.28%
ATYR Quarterly EBITDA YoY % (-14.65% → 45.28%)
High-resolution chart · PNG

ATYR ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Atyr Pharma Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
45.2808%
28.2867%
8.2674%
-50.2815%
-20.2349%
1.4881%
-3.0584%
-63.0399%
-35.4457%
-31.437%
-110.2842%
19.3438%
3.1232%
5.5584%
17.1702%
-74.8093%
-20.9388%
-71.7017%
-75.5646%
-18.1584%
-68.4688%
-411.4569%
16.328%
-20.4576%
-12.2926%
140.0108%
3.0083%
20.4903%
45.7002%
44.7888%
47.6039%
39.2412%
16.7476%
22.7108%
10.2958%
21.7547%
22.8549%
18.2408%
24.3034%
-23.0318%
-42.2998%
-82.2794%
-181.0199%
-84.1415%
-107.3327%
-52.139%
-14.6453%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.